The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Risedronate Pinewood 5 mg film-coated tablets

Pinewood Laboratories LtdPA0281/158/001

Main Information

Trade NameRisedronate Pinewood 5 mg film-coated tablets
Active SubstancesRisedronate sodium
Dosage FormFilm-coated tablet
Licence HolderPinewood Laboratories Ltd
Licence NumberPA0281/158/001

Group Information

ATC CodeM05BA Bisphosphonates
M05BA07 risedronic acid


License statusWithdrawn
Withdrawn Date13/07/2023
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back